Litigation Details for AstraZeneca AB v. Alembic Pharmaceuticals Limited (D. Del. 2021)
✉ Email this page to a colleague
AstraZeneca AB v. Alembic Pharmaceuticals Limited (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-07-02 |
Court | District Court, D. Delaware | Date Terminated | 2022-04-25 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 10,183,020 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Alembic Pharmaceuticals Limited
Details for AstraZeneca AB v. Alembic Pharmaceuticals Limited (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-04-25 | 15 | Judgment - Consent | assigns, is enjoined from infringing U.S. Patent No. 10,183,020, on its own part or through any Affiliate…2021 25 April 2022 1:21-cv-00982 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-04-25 | 16 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,183,020. (Attachments: # 1…2021 25 April 2022 1:21-cv-00982 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |